Jelena Mann

Chief Executive Officer @Fibrofind

Newcastle Upon Tyne, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2019 — Present

Chief Executive Officer @Fibrofind

View department →

Newcastle upon Tyne, GB

EDUCATION

1994 — 1997

University of Southampton

Bachelor of Science (B.Sc.)

1997 — 2001

University of Southampton

Doctor of Philosophy (PhD), Medicine

SKILLS

ScienceBiochemistryResearchManagementHigher EducationLife SciencesTeamworkLeadershipTeachingData AnalysisWestern BlottingCell BiologyPublic SpeakingMolecular BiologyCell Culture

ABOUT JELENA MANN

Liver fibrosis is a final common pathway of liver injury irrespective of aetiology. It is characterised by progressive replacement of normal hepatic tissue with collagen-rich scar tissue and is responsible for around 1.5 million death per annum worldwide. There are no proven effective therapeutics for fibrosis, the only treatment available for chronic liver disease is transplantation which is limited by availability of donor organs. I am interested in delineating epigenetic signalling pathways that trigger fibrogenesis and in doing so, discovering molecular control of fibrogenesis and associated signalling pathways that can be targeted with new as well as existing drugs. More recently we have also embarked on studies that test the ability of environmental factors to affect transgenerational inheritance of predisposition to liver fibrosis. Adaptation to environmental insults is critical for ensuring fitness and survival of the species, however it is currently not clear if predisposition to development of fibrosis exists or indeed if existence of disease in previous generations alters such predisposition. We have published the first report of the transgenerational epigenetic transmission of protection against liver fibrosis which provides evidence of heritable mechanisms for the rapid adaptation of animals to environmental insults. The lab is now carrying out further characterisation of this newly reported phenomena and its impact on liver disease of various aetiology.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Jelena Mann — Chief Executive Officer at Fibrofind in Newcastle Upon Tyne, GB | Unifers